Used primarily in pharmacological research, dihydrolycorine is studied for its potential effects on the central nervous system. It has shown promise in preliminary studies for its neuroprotective properties, which could be beneficial in treating neurodegenerative diseases. Additionally, it is being explored for its role in modulating neurotransmitter activity, which might help in understanding and managing conditions like depression and anxiety. Researchers are also investigating its potential antitumor properties, particularly in inhibiting the growth of certain cancer cells. Its application in these areas remains experimental, with ongoing studies to better understand its efficacy and safety profile.